Declarations, Schedule, Policy Declarations CLASS LIMIT OF ...
Arrow declarations webinar, Mark Daniels, March 2017
-
Upload
browne-jacobson-llp -
Category
Law
-
view
31 -
download
0
Transcript of Arrow declarations webinar, Mark Daniels, March 2017
![Page 1: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/1.jpg)
Have your say @brownejacobson
'Arrow' declarationslessons from Fujifilm v AbbVie
![Page 2: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/2.jpg)
Have your say @brownejacobson
'Arrow' declarationslessons from Fujifilm v AbbVie
Connect with Mark
+44 (0)121 237 3993
![Page 3: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/3.jpg)
Have your say @brownejacobson
Thank you forjoining todayFollow us on LinkedIn fornews, legal updates, realopinions and training:https://www.linkedin.com/company/technology---cyber-security
![Page 4: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/4.jpg)
Have your say @brownejacobson
'Arrow' declarationslessons from Fujifilm v AbbVie
Connect with Mark
+44 (0)121 237 3993
![Page 5: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/5.jpg)
Have your say @brownejacobson
The English Patents Court – a forum fordeclaratory relief• an innovative forum• Civil Procedure Rules – CPR
40.20• Messier Dowty v Sabena• Nokia Corp v InterDigital• Arrow Generics v Merck & Co
Ltd
• FSA v Rourke– justice to the Claimant– justice to the Defendant– useful purpose– special reasons
![Page 6: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/6.jpg)
Have your say @brownejacobson
Statutory declarations• non-infringement – section
71 Patents Act 1977• invalidity (+ revocation) -
section 74(2) Patents Act1977
![Page 7: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/7.jpg)
Have your say @brownejacobson
Court’s inherentjurisdiction under CPR40.20• non-essentiality (and
essentiality) to a technicalstandard (Nokia vInterDigital)
• whether licences offered inrespect of SEPs are FRAND(Unwired Planet v Huawei)
![Page 8: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/8.jpg)
Have your say @brownejacobson
Court’s inherentjurisdiction under CPR40.20• that the Defendant’s
product was obvious at thepriority date of a patentapplication (not yetgranted) (Arrow and nowhere for real in FKB)
![Page 9: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/9.jpg)
Have your say @brownejacobson
Fujifilm v AbbVie• the background• why it mattered - the
market and the patents• the proceedings• strike out and AbbVie’s
offer
![Page 10: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/10.jpg)
Have your say @brownejacobson
The FSA v Rourkeconsiderationsapplied• useful purpose• justice to the Claimants and
the Defendants• any special reasons to grant
or not grant
![Page 11: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/11.jpg)
Have your say @brownejacobson
Furtherconsiderations• the opening of floodgates?• expert guidance• the court’s approach to
dosage regimens
![Page 12: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/12.jpg)
Have your say @brownejacobson
Connect with Mark
+44 (0)121 237 3993
Keep your questions comingor get in touch if you have a specific query
![Page 13: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/13.jpg)
Have your say @brownejacobson
Thank you forjoining todayFollow us on LinkedIn fornews, legal updates, realopinions and training:https://www.linkedin.com/company/technology---cyber-security
![Page 14: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/14.jpg)
Have your say @brownejacobson
The cases mentioned today• Fujifilm Kyowa Kirin Biologics Company Ltd, Samsung Bioepsis UK Ltd
and Biogen Idec Ltd (together “FKB”) v AbbVie Biotechnology Ltd[2017] EWHC 395 (Pat)
• Messier Dowty v Sabena [2001] 1 All ER (Lord Woolf MR)• Financial Services Authority v Rourke [2002] CP Rep 14 (Neuberger J)• Nokia Corp v InterDigital Technology Corp [2007] EWHC 3077 (Pat)
(Pumfrey J)• Arrow Generics v Merck & Co Ltd [2007] EWHC 1900 (Pat) (Kitchin J)• Unwired Planet v Huawei [2015] EWHC 1029 (Pat)
![Page 15: Arrow declarations webinar, Mark Daniels, March 2017](https://reader031.fdocuments.in/reader031/viewer/2022030307/58e5f3961a28ab09478b4947/html5/thumbnails/15.jpg)
Have your say @brownejacobson
Connect with Mark
+44 (0)121 237 3993
Keep your questions comingor get in touch if you have a specific query